450 Brookline Avenue
Boston, MA 02115
United States
Harvard University - Dana-Farber Cancer Institute
HR+/HER2- metastatic breast cancer, CDK4/6 inhibitor resistance, Systematic Review, Network meta-analysis, Biomarker-driven therapy, Antibody-drug conjugates